Cite
HARVARD Citation
Reed, S. et al. (2021). Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism. European journal of contraception & reproductive health care. pp. 439-446. [Online].